Empowered Funds LLC Takes $4.13 Million Position in Globe Life Inc. $GL

Empowered Funds LLC bought a new stake in Globe Life Inc. (NYSE:GL) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 23,134 shares of the company’s stock, valued at approximately $4,134,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Hilton Head Capital Partners LLC acquired a new position in shares of Globe Life in the 4th quarter valued at $30,000. Johnson Financial Group Inc. acquired a new stake in shares of Globe Life during the 2nd quarter valued at about $39,000. CYBER HORNET ETFs LLC acquired a new stake in shares of Globe Life during the 2nd quarter valued at about $28,000. MUFG Securities EMEA plc bought a new stake in Globe Life in the second quarter valued at about $31,000. Finally, AdvisorNet Financial Inc increased its stake in Globe Life by 41.1% in the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after acquiring an additional 92 shares during the period. 81.61% of the stock is owned by institutional investors.

Globe Life Trading Down 0.1%

Shares of Globe Life stock opened at $172.59 on Tuesday. The stock has a market capitalization of $13.26 billion, a P/E ratio of 11.46 and a beta of 0.48. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. The company has a 50-day simple moving average of $178.78 and a 200 day simple moving average of $159.87. Globe Life Inc. has a 12-month low of $127.85 and a 12-month high of $191.55.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.52%. Globe Life’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter last year, the firm earned $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Research analysts expect that Globe Life Inc. will post 15.71 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be paid a $0.33 dividend. The ex-dividend date is Monday, October 5th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life’s payout ratio is 8.76%.

Globe Life announced that its Board of Directors has approved a stock repurchase program on Monday, August 10th that allows the company to buyback $2.50 billion in outstanding shares. This buyback authorization allows the company to buy up to 17.7% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s board believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on GL shares. Weiss Ratings lowered shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. Piper Sandler upped their price objective on Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. JPMorgan Chase & Co. increased their target price on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a report on Tuesday, July 21st. Morgan Stanley raised their target price on Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Finally, Wells Fargo & Company boosted their price target on Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, Globe Life currently has a consensus rating of “Moderate Buy” and a consensus price target of $191.67.

Insider Buying and Selling

In related news, CEO James Matthew Darden sold 50,000 shares of the firm’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the completion of the sale, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at $10,663,215.93. This trade represents a 46.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Cheryl Alston sold 8,258 shares of the firm’s stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total value of $1,480,163.92. Following the sale, the director directly owned 16,621 shares of the company’s stock, valued at $2,979,148.04. This represents a 33.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 151,908 shares of company stock valued at $27,239,981 in the last ninety days. 2.11% of the stock is owned by corporate insiders.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.